High Powered Computational Tools Are Bringing Changes to Clinical Trial Design

As High-Performance Computing (HPC) becomes more widespread and accessible, even for relatively small companies, clinical trial design is expected to shift and evolve. Processes that used to take months of in-depth analysis now take days. Notably, statisticians are expected to adapt to these new technologies while being able to communicate findings to other team members, including both scientists and non-scientists. A new whitepaper discusses the coming changes.

“Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics, computational biology, cryo-electron microscopy, and numerous others forms of scanning, sequencing, and simulation. Yet there have been few reports of how computational power can affect the design and operations of clinical trials. A new whitepaper by Cytel highlights how revolutions in computing are now set to transform clinical studies, and how sponsors can remain competitive in this modern industry terrain by learning to harness the power of new technology.” Read more here.

(Source: Cytel, 3/18/21)